98%
921
2 minutes
20
Depression is a disorder that affects people's quality of life and its main characteristic is loss of interest. Symptoms can occur at any stage of the life cycle, including in the academic environment. In addition to the influence of the environment in which they are inserted, genetic factors such as the presence of polymorphic variants in certain genes, as well as the inflammatory process, can be related to depression, affecting its onset, progression and treatment. Thus, the aim of the study was to investigate the role of Val16Ala polymorphism in relation to depressive symptoms in university students according to the DASS-21 scale, and whether or not it has the capacity to accentuate symptoms through inflammatory processes. In this study, 244 university students were recruited, who self-completed the DASS-21, anthropometric measurements and biological material were collected, and through the DASS-21 they were classified into two groups, depressed and non-depressed. Our results showed differences between anthropometric markers in depressed and non-depressed women; there were differences between leptin, hsCRP and IL1B. In addition to the biological markers measured, there were significant differences in relation to the students' lifestyle, such as physical activity and sleep quality. Taking into account the polymorphism, it is possible to observe that it was not related to depressive symptoms, inflammatory and antioxidant processes, however, nitrite levels and female gender were independent risk factors for depression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/smi.70073 | DOI Listing |
J Med Internet Res
September 2025
School of Pharmacy, Sungkyunkwan University, Gyeonggi-do, Republic of Korea.
Background: Owing to the unique characteristics of digital health interventions (DHIs), a tailored approach to economic evaluation is needed-one that is distinct from that used for pharmacotherapy. However, the absence of clear guidelines in this area is a substantial gap in the evaluation framework.
Objective: This study aims to systematically review and compare the economic evaluation literature on DHIs and pharmacotherapy for the treatment of depression.
JAMA Psychiatry
September 2025
Denovo Biopharma LLC, San Diego, California.
Importance: This study represents a first successful use of a genetic biomarker to select potential responders in a prospective study in psychiatry. Liafensine, a triple reuptake inhibitor, may become a new precision medicine for treatment-resistant depression (TRD), a major unmet medical need.
Objective: To determine whether ANK3-positive patients with TRD benefit from a 1-mg and/or 2-mg daily oral dose of liafensine, compared with placebo, in a clinical trial.
Neurochem Res
September 2025
Biology and Health Laboratory, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.
Parkinson's disease (PD) is characterized by impairments in motor control following the degeneration of dopamine-producing neurons located in the substantia nigra pars compacta. Environmental pesticides such as Paraquat (PQ) and Maneb (MB) contribute to the onset of PD by inducing oxidative stress (OS). This study evaluated the therapeutic efficacy of moderate physical activity (PA) on both motor and non-motor symptoms in a Wistar rat model of Paraquat and Maneb (PQ/MB) induced PD.
View Article and Find Full Text PDFInfect Dis Ther
September 2025
Department of Nursing, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China.
Introduction: Cognitive frailty (CF), which typically precedes dementia and functional decline, serves as a more robust predictor of adverse health outcomes compared to physical frailty alone, representing a critical challenge in promoting healthy aging among older people living with HIV (PLWH) aged ≥ 50 years. This study aimed to investigate the prevalence of cognitive frailty and identify its associated factors among PLWH aged ≥ 50 years.
Methods: A convenience sample of 344 PLWH ≥ 50 years was recruited from a tertiary Grade A hospital in Zunyi, China.
Int Urogynecol J
September 2025
Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, USA.
Introduction And Hypothesis: Depressive and anxiety symptoms are known risk factors for lower urinary tract symptoms (LUTS). To inform prevention and treatment strategies, this research examined whether greater emotional support seeking weakened associations of affective symptoms with LUTS and poorer bladder health.
Methods: Data were collected from women in the USA who participated in the RISE FOR HEALTH study of bladder health.